Press Releases

Category

from

to

Showing 121 - 135 of 4099 between Jan 2004 and Jul 2018


A randomized, double-blind, placebo-controlled trial published in Biological Psychiatry shows that sodium benzoate improves symptoms in clozapine-resistant schizophrenia


Elsevier’s collaboration with the National University of Science and Technology MISIS will be expanded to support its engineering research and innovation projects


Patients in Nova Scotia who are farther away from Halifax have higher mortality, according to a new study in the Canadian Journal of Cardiology


Start-ups working on a range of technologies and discoveries – from AI to immunotherapy – receive complimentary access to Elsevier’s information solutions to accelerate innovation


For second year in a row, global evidence-based solution recognized in ‘Clinical Decision Support – Care Plans/Order Sets’ category


Intravenous bevacizumab should be considered as a first-line therapy for the treatment of refractory bleeding in patients with severe hereditary hemorrhagic telangiectasia, reports Mayo Clinic Proceedings


New study provides reassurance for men taking blood pressure and cholesterol modifying medications, reports the Canadian Journal of Cardiology


Scientists are debating whether and why it appears that the number of species at sites worldwide is holding steady (even increasing at many), as biodiversity declines globally.


Initiative aims to support the delivery and unification of evidence-based care


Major new study confirms adolescent drinking can predict risk of developing liver disease later in life and suggests guidelines for safe alcohol intake in men might need to be changed, report investigators in the Journal of Hepatology


Risks are higher for asymptomatic paroxysmal AF patients than symptomatic paroxysmal AF patients, according to a new study in the journal CHEST®


While there might be sufficient replacement staff, complications remain, according to a new study in the American Journal of Preventive Medicine


Joint FinELib and Elsevier press release



Elsevier’s clinical solutions portfolio will be extended by Via Oncology’s evidence-based cancer treatment pathways, integrating Elsevier’s content, technology and analytics